000 01711nam a2200421 a 4500
001 EBC3019875
003 MiAaPQ
005 20240123084752.0
006 m o d |
007 cr cn|||||||||
008 100122s2010 nyuab sb 001 0 eng d
010 _z 2010002978
020 _z9781616682330 (softcover)
020 _z1616682337 (softcover)
020 _a9781616684785 (electronic bk.)
035 _a(MiAaPQ)EBC3019875
035 _a(Au-PeEL)EBL3019875
035 _a(CaPaEBR)ebr10674883
035 _a(OCoLC)923662021
040 _aMiAaPQ
_cMiAaPQ
_dMiAaPQ
050 4 _aRM409
_b.V56 2010
082 0 4 _a615.5/8
_222
100 1 _aVinsova, Jarmila.
245 1 0 _aDevelopment of new MDR-tuberculosis drugs
_h[electronic resource] /
_cJarmila Vinsova and Martin Kratky.
260 _aNew York :
_bNova Science Publishers/Nova Biomedical,
_cc2010.
300 _axii, 98 p. :
_bill., map.
490 1 _aPharmacology-research, safety testing and regulation
504 _aIncludes bibliographical references and index.
505 0 _aResistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.
533 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aAntitubercular agents.
650 0 _aMultidrug-resistant tuberculosis
_xChemotherapy.
655 4 _aElectronic books.
700 1 _aKratky, Martin,
_d1960-
710 2 _aProQuest (Firm)
830 0 _aPharmacology-research, safety testing, and regulation series.
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3019875
_zClick to View
999 _c153288
_d153287